$20.14
0.633.23%
At close: -
$20.14
0.000.00%
After Hours: Jun 6, 4:00 PM EDT
Comments
Loading...
NewAmsterdam Pharma Co Earnings Estimates, EPS & Revenue | NASDAQ:NAMS | Benzinga
NewAmsterdam Pharma Co reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS
$-0.340
Quarterly Revenue
$2.98M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$47.14M
Analyze the earnings history of NewAmsterdam Pharma Co using advanced sorting and filters.
NewAmsterdam Pharma Co (NAMS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-08 | $-0.34 | $-0.44 | 22.7 % |
NewAmsterdam Pharma Co (NAMS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-08 | $2.98M | $1.46M | 104.0 % |
FAQ
When is NewAmsterdam Pharma Co (NASDAQ:NAMS) reporting earnings?
NewAmsterdam Pharma Co (NAMS) is scheduled to report earnings on August 6, 2025. The last reported earnings were for reported on May 8, 2025 for Q1.
What were the latest earnings per share (EPS) for NewAmsterdam Pharma Co (NASDAQ:NAMS)?
The Actual EPS was $-0.34, which beat the estimate of $-0.44.
What were NewAmsterdam Pharma Co’s (NASDAQ:NAMS) revenues?
The Actual Revenue was $3M, which beat the estimate of $1.5M.
Browse earnings estimates, EPS, and revenue on all stocks.
